Source record
A weekly glucose-pattern note for the diabetes visit
この言語の本文は未訳のため、英語で表示しています。
This source is an illustrative composite written by Madical AI Use on 14 September 2026. It is not a glucose-outcome study and it quotes no time-in-range result, hypoglycemia rate, or insulin-dose change. It describes a clinician-edited summary of a continuous-glucose export. The ADA Standards of Care are cited only because they already discuss glucose-monitoring metrics. FDA’s artificial-pancreas materials are cited to mark closed-loop systems as a separate regulated class.
- Source date
- 2026年9月14日 · 年 2026
- Evidence label
- 例示
- Source type
- 病院
Citation
Illustrative composite, Madical AI Use
Madical AI Use. Illustrative composite: a weekly glucose-pattern note for the diabetes visit. Index entry dated 14 September 2026. Not a peer-reviewed paper or a device study.
Key public facts
- The draft is built from a continuous-glucose export the clinic already receives.
- The note may mention time in range, overnight lows, and days that look different. Those phrases describe the file. They are not measured outcomes of this composite.
- The clinician edits the draft and decides any insulin change.
- Autonomous dosing is excluded.
- Closed-loop insulin systems are separate regulated devices and are not this workflow.
References used to construct the scenario
- American Diabetes Association. Standards of Care in Diabetes. Cited for the existence of public glucose-monitoring guidance, not as a result of this composite.
- U.S. Food and Drug Administration. Artificial pancreas device systems. Cited to mark automated insulin delivery as a separate regulated class.
教育と市場把握のための条目。医療助言でも推奨でもありません。